-
Hexetidine: From Membrane Stress to Oral Translation
2026-09-10
Hexetidine (NSC-17764) illustrates why oral antimicrobial development must connect membrane-level activity with matrix effects, biofilm biology, exposure duration, and clinically relevant endpoints. This thought-leadership article interprets foundational mouthrinse data and translates it into practical assay and development strategies for researchers studying oral infections, dental plaque, gingivitis, and Candida-associated biofilms.
-
Hexetidine (NSC-17764): Oral Antimicrobial Evidence
2026-09-09
Hexetidine (NSC-17764) is a broad-spectrum oral antimicrobial with reported activity against bacteria and Candida albicans. Its evidence supports oral infection research, biofilm inhibition assay design, and dental plaque reduction, but not SARS-CoV-2 protease inhibition.
-
Magnetic Stimulation and GABRE in Schizophrenia-Like Mice
2026-09-09
This reference study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a selective molecular target for magnetic neuromodulation. Using behavioral, synaptic, genetic, and protein-level experiments, the authors show that targeted stimulation can reverse schizophrenia-like phenotypes and implicate p62/SQSTM1–GABARAP trafficking in GABRE regulation.
-
Palomid 529 (P529) in ESCC Research
2026-09-08
Palomid 529 (P529) is a dual mTORC1 and mTORC2 inhibitor for preclinical cancer research. Its reported activity against endothelial proliferation and the PI3K/Akt/mTOR signaling pathway supports studies of tumor angiogenesis inhibition, radiotherapy enhancement, metastasis, and cisplatin resistance.
-
Quinolone–Coumarin Hybrids Against Toxoplasma gondii
2026-09-08
The reference study evaluates 12 quinolone–coumarin hybrids derived from fluoroquinolone and novobiocin-related scaffolds against Toxoplasma gondii in vitro. QC1, QC3, QC6, and novobiocin showed the most favorable combination of antiparasitic activity and host-cell selectivity, supporting further investigation while remaining limited to cell-based evidence.
-
Dual Recombinase Tracing and No Neo-Oogenesis
2026-09-07
Xie, Zhou, and Zheng used orthogonal Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that in vivo neo-oogenesis does not replenish the mouse oocyte pool.
-
Hydroxychloroquine Sulfate: Practical Guide
2026-09-05
Hydroxychloroquine Sulfate (SKU B4874) provides a water-compatible research reagent for studying autophagy pathway modulation and TLR7/9 signaling in autoimmune disease research. Its dossier supports aqueous preparation and a 5 μM TLR7/9 assay point, but it is not suitable for DMSO- or ethanol-based workflows or long-term solution storage.
-
Hexetidine (NSC-17764): Oral Antimicrobial Evidence
2026-09-05
Hexetidine, also identified as NSC-17764, is a broad-spectrum oral antimicrobial with activity against bacteria and Candida albicans. Product and mouthwash-model evidence supports strain-specific MIC testing, biofilm workflows, dental plaque reduction, and gingivitis treatment while defining important limits related to adsorption, formulation, and antiviral interpretation.
-
CTCF Maintains Centromere Function in Mitosis
2026-09-04
Walsh and colleagues use rapid auxin-inducible degradation to show that CTCF is required for centromere mechanics, chromosome alignment, mitotic fidelity, and post-mitotic nuclear shape. The study separates this architectural role from simple CENP-E recruitment defects and supports a model in which CTCF helps maintain centromere function, potentially through chromatin organization related to cohesin.
-
Partial BACE Inhibition and Synaptic Transmission in AD
2026-09-04
Satir and colleagues tested whether moderate β-secretase inhibition can lower amyloid-β production without disrupting neuronal communication. Using primary rat cortical cultures, optical electrophysiology, and secreted Aβ measurements, they found that reductions of less than 50% were compatible with preserved synaptic transmission, whereas stronger inhibition impaired it.
-
TREM2, ERK/p38, and Microglia in Autoimmune Uveitis
2026-09-03
The reference study identifies TREM2 as an anti-inflammatory regulator of microglia in experimental autoimmune uveitis, linking its protective activity to suppression of ERK/p38-associated signaling. Its combined mouse, BV2-cell, molecular, flow-cytometric, and RNA-sequencing design provides a framework for connecting microglial state with retinal vascular leakage and systemic T-cell imbalance.
-
Pexmetinib (ARRY-614) Assay Workflows
2026-09-03
Pexmetinib (ARRY-614) supports experimentally tractable studies of inflammatory cytokine inhibition by combining p38 MAPK and Tie2 pathway modulation. This workflow-focused guide covers solvent handling, cellular and whole-blood assays, phospho-signaling readouts, and troubleshooting for inflammation and myelodysplastic syndromes research.
-
2,2,2-Trichloroethanol for Protein Analysis
2026-09-02
Learn how to integrate 2,2,2-Trichloroethanol into protein electrophoresis, gel imaging, and assay-quality workflows. Practical concentration screens, normalization controls, troubleshooting guidance, and a carefully bounded connection to dopamine-neuron maturation research help distinguish useful applications from unsupported claims.
-
DiI (DiIC18(3)) Plasma Membrane Probe
2026-09-02
DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for labeling live or fixed cells and tissues, supporting membrane visualization, neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows. It is water-insoluble and should not be treated as an aqueous stain or a selective intracellular-organelle probe; solvent choice, fixation, and permeabilization require validation.
-
Fenipentol: From Natural Product to Assay Probe
2026-09-01
Fenipentol is more than a volatile constituent of Chuanxiong: it is a tractable probe for connecting chemical profiling, ESR1-related hypotheses, and gastrointestinal secretion phenotypes. This evidence-centered guide explains how to design, interpret, and de-risk Fenipentol experiments without confusing molecular docking with biological validation.